About 30 million babies are born each year in parts of Sub-Saharan Africa where malaria spreads. In July 2025 Swissmedic approved Coartem Baby, the first antimalarial made for newborns and infants under five kilograms. Novartis and the not-for-profit MMV developed the medicine.
Before this approval, health workers often had to use adult drugs in improvised ways and that could cause underdosing or overdosing. Experts say maternal antibodies fade within weeks, so newborns quickly become exposed. Eight African countries joined the review and promised to fast-track national approvals within 90 days.
Difficult words
- malaria — A serious disease spread by mosquitoes.malaria is
- medicine — A substance used to treat illness.medicine meant
- approved — Officially accepted or allowed.
- treatment — Care to help someone feel better.
- vulnerable — Easily harmed or hurt.
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Why do you think newborns were often excluded from drug studies?
- How can new medicines help vulnerable groups in the future?
Related articles
Tanzania fights rabies with mass dog vaccination
Tanzania is working to stop human rabies by vaccinating dogs, improving surveillance and keeping vaccines cold. High vaccine costs, remote villages and lack of electricity remain challenges, but local and international efforts are growing.
Worry about police linked to heart risk in Black women
A US study of 422 Black women found that worry about police interactions—especially concern for their children—was associated with thicker carotid artery measurements, a marker of cardiovascular risk. The study shows correlation, not causation.
Joha rice may help prevent diabetes and protect the heart
Researchers in India report that Joha, a scented short-grain rice from the northeast, showed benefits in lab and rat studies against type 2 diabetes and heart disease. Tests found healthy fats, antioxidants and improved insulin response.
